Contaminant in the recalled unfractionated heparin preparations: where is the problem?
Debra A
DA
Hoppensteadt
Rakesh
R
Wahi
Cafer
C
Adiguzel
Omer
O
Iqbal
Eduardo
E
Ramacciotti
Rodger L
RL
Bick
Harry L
HL
Messmore
Vinod
V
Bansal
Jawed
J
Fareed
D000818:Animals; D000925:Anticoagulants / Q000009:adverse effects* / Q000302:isolation & purification / Q000592:standards; D004340:Drug Contamination / Q000331:legislation & jurisprudence / Q000517:prevention & control; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence; D006493:Heparin / Q000009:adverse effects* / Q000302:isolation & purification / Q000592:standards; D006801:Humans; D011786:Quality Control; D034421:Sus scrofa; D014481:United States; D014486:United States Food and Drug Administration
D000925:Anticoagulants; D006493:Heparin